Παρασκευή 26 Φεβρουαρίου 2016

Chemoprevention in Barrett's Esophagus: Current Status.

http:--linkinghub.elsevier.com-ihub-imag Related Articles

Chemoprevention in Barrett's Esophagus: Current Status.

Gastroenterol Clin North Am. 2015 Jun;44(2):391-413

Authors: Zeb MH, Baruah A, Kossak SK, Buttar NS

Abstract
Chemoprevention in Barrett's esophagus is currently applied only in research settings. Identifying pathways that can be targeted by safe, pharmaceutical or natural compounds is key to expanding the scope of chemoprevention. Defining meaningful surrogate markers of cancer progression is critical to test the efficacy of chemopreventive approaches. Combinatorial chemoprevention that targets multiple components of the same pathway or parallel pathways could reduce the risk and improve the efficacy of chemoprevention. Here we discuss the role of chemoprevention as an independent or an adjuvant management option in BE-associated esophageal adenocarcinoma.

PMID: 26021201 [PubMed - indexed for MEDLINE]



from Swallowing and Swallowing Disorders (Dysphagia) via a.lsfakia on Inoreader http://ift.tt/1KPSdj3
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου